Add Yahoo as a preferred source to see more of our stories on Google. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood ...
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily, new study suggests. Half of all patients discharged from hospital after a heart attack ...
Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the symptoms of a heart attack. Cardiovascular diseases (CVDs) are the leading ...
Blavity on MSN
What do beta-blockers actually do?
When performance anxiety kicks in, it often triggers a racing heart and trembling hands.
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...
The benefit of beta-blockers after myocardial infarction in patients with a preserved left ventricular ejection fraction (LVEF) is unclear. We conducted a meta-analysis at the individual-patient level ...
LONDON — It may not be advisable for patients with a history of myocardial infarction and preserved left ventricular function to discontinue long-term beta-blocker therapy, warn investigators. In the ...
Please provide your email address to receive an email when new articles are posted on . Beta-blockers have traditionally been prescribed for chronic coronary syndromes. Recent guidelines have ...
The Hearty Soul on MSN
Common heart drug may do more harm than good in older people
New clinical trials show beta-blockers offer no benefit and may raise risks for older heart attack survivors with normal heart function. The post Common Heart Drug May Be Doing More Harm Than Good in ...
Among stable, relatively low-risk patients who had previously suffered a heart attack, discontinuing beta-blockers after at least one year was found to be non-inferior, or comparable, to continuing ...
The findings confirm the results of the CNIC-led REBOOT clinical trial and consolidate a paradigm shift in infarction treatment. A major analysis led by the Centro Nacional de Investigaciones ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results